治療的指示を持つ経口プロゲスタゲン製剤と関連した心血管疾患のリスク
Lancet (London, England)
|November 24, 1999
まとめ
治療目的のプロゲスタゲン製剤は,静脈性血栓塞栓症のリスクを大幅に増加させる. しかし,これらの治療は脳卒中や心筋梗塞のリスクを高めるようには見えません.
科学分野:
- 医薬品監視 医薬品監視
- 心血管の健康について
- 血栓性疾患 血栓性疾患 血栓性疾患 血栓性疾患 血栓性疾患 血栓性疾患 血栓性疾患 血栓性疾患
背景:
- プロゲスタゲンは,様々な治療目的で広く使用されています.
- プロゲスタゲン製剤の安全性プロファイルを理解することは,臨床実務において極めて重要です.
- プロゲスタゲンと主要な心血管疾患の有害事象との関連に関する既存のデータは限られている.
研究 の 目的:
- プロゲスタゲン製剤の使用と治療的徴候の関連性,および主要な心血管疾患の有害事象のリスクの関連性を調査する.
- 静脈血栓塞栓症,脳卒中,心筋梗塞のリスクを具体的に検討する.
主な方法:
- 世界保健機関 (WHO) の共同研究から得られたデータを活用した.
- プロゲスタゲン使用に関連して静脈血栓塞栓症,脳卒中,心筋梗塞の発生率を分析した.
- リスク関連性を評価するために,疫学的な方法を用いた.
主要な成果:
- 治療目的のプロゲスタゲン製剤は,静脈性血栓塞栓症のリスクの増加と有意に関連していました.
- プロゲスタゲンの使用と脳卒中のリスクとの間に有意な関連性は見つかりませんでした.
- 同様に,プロゲスタゲンの使用と心筋梗塞のリスクとの間に有意な関連性が見られなかった.
結論:
- 治療目的でのプロゲスタゲン製剤の使用は,静脈血栓塞栓症の顕著なリスクを伴う.
- 臨床医は,プロゲスタゲンを処方する際に,このリスクを慎重に考慮する必要があります.
- この関連を裏付けるメカニズムを探るため,さらなる研究が必要になるかもしれません.
関連する概念動画
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...